Work

High-Resolution Analysis of the Relationship Between Ponatinib Dose and Molecular Response in CP-CML Patients in the PACE Trial

Year: 2015

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2015.04.077

Authors: Justin R. Pritchard, Stephanie Lustgarten, Graeme Hodgson, Michele Baccarani, Jorge E. Cortes, Michael W. Deininger, Francois Guilhot, Andreas Hochhaus, Timothy P. Hughes, Neil P. Shah, Moshe Talpaz, Tim Clackson, Frank G. Haluska, Ronald Knickerbocker, Victor M. Rivera

Institutions: ARIAD Pharmaceuticals (United States), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, The University of Texas MD Anderson Cancer Center, Huntsman Cancer Institute, Jena University Hospital, South Australia Pathology, University of California, San Francisco, University of Michigan, U-M Rogel Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2291819686

FWCI:

Cites:

Cited by:

Related to: 10